CAMPTOTHECIN INHIBITS TAT-MEDIATED TRANSACTIVATION OF TYPE-I HUMAN-IMMUNODEFICIENCY-VIRUS

被引:0
|
作者
LI, CJ
WANG, CL
PARDEE, AB
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcription of type I human immunodeficiency virus (HIV-I) is governed by the viral long terminal repeat (LTR). By using HTV-1 LTR-directed reporter gene systems, we found that the DNA topoisomerase I inhibitor camptothecin inhibits Tat-mediated transactivation of HIV-1 LTR. The 293.27.2 cells that carry a stably transfected HIV-1 LTR-directed lacZ gene expression vector (pNAZ) were used. Inhibitions of LTR were observed at camptothecin concentrations (IC50 about 0.03 mu m, which was an order of magnitude lower than for Ro 24-7429), which had minor effects on cell survival, expression of the cellular gene gro, or Rous sarcoma virus-directed chloramphenicol acetyltransferase (CAT) gene expression. Inhibition was also seen with RPMI 8402, which is a human CD4-positive lymphocyte line transiently transfected with a HIV-1 LTR-directed (CAT) gene. Experiments with HIV-1 LTR mutants suggest that transactivation response sequence but not NF-kappa B is responsible for the inhibition by camptothecin. The target for camptothecin may be a cellular factor that is important for the activation of HIV-1 LTR by Tat and thus may offer a potential target for therapy of HIV-1 infection.
引用
收藏
页码:7051 / 7054
页数:4
相关论文
共 50 条
  • [1] Celastrol Inhibits Tat-Mediated Human Immunodeficiency Virus (HIV) Transcription and Replication
    Narayan, Vivek
    Ravindra, Kodihalli C.
    Chiaro, Chris
    Cary, Daniele
    Aggarwal, Bharat B.
    Henderson, Andrew J.
    Prabhu, K. Sandeep
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2011, 410 (05) : 972 - 983
  • [2] TRANSCELLULAR TRANSACTIVATION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    HELLAND, DE
    WELLES, JL
    CAPUTO, A
    HASELTINE, WA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (08) : 4547 - 4549
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-MEDIATED TRANSACTIVATION CORRELATES WITH THE PHOSPHORYLATION STATE OF A CELLULAR TAR RNA STEM-BINDING FACTOR
    HAN, XM
    LARAS, A
    ROUNSEVILLE, MP
    KUMAR, A
    SHANK, PR
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4065 - 4072
  • [4] Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat
    Barthelemy, S
    Vergnes, L
    Moynier, M
    Guyot, D
    Labidalle, S
    Bahraoui, E
    [J]. RESEARCH IN VIROLOGY, 1998, 149 (01): : 43 - 52
  • [5] The integrase interactor I (INII) proteins facilitate Tat-mediated human immunodeficiency virus type I transcription
    Ariumi, Yasuo
    Serhan, Fatima
    Turelli, Priscilla
    Telenti, Amalio
    Trono, Didier
    [J]. RETROVIROLOGY, 2006, 3 (1)
  • [6] INFECTION OF THE RETINA BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I
    POMERANTZ, RJ
    KURITZKES, DR
    DELAMONTE, SM
    ROTA, TR
    BAKER, AS
    ALBERT, D
    BOR, DH
    FELDMAN, EL
    SCHOOLEY, RT
    HIRSCH, MS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (26): : 1643 - 1647
  • [7] TAT AND REV DIFFERENTIALLY AFFECT RESTRICTED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I IN VARIOUS CELLS
    DUAN, LX
    OAKES, JW
    FERRARO, A
    BAGASRA, O
    POMERANTZ, RJ
    [J]. VIROLOGY, 1994, 199 (02) : 474 - 478
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I - INFECTION AMONG DENTISTS
    GRUNINGER, SE
    SIEW, C
    CHANG, SB
    CLAYTON, R
    LEETE, JK
    HOJVAT, SA
    VERRUSIO, AC
    NEIDLE, EA
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1992, 123 (03): : 57 - 64
  • [9] FOLDING OF THE MULTIDOMAIN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I INTEGRASE
    GRANDGENETT, DP
    GOODARZI, G
    [J]. PROTEIN SCIENCE, 1994, 3 (06) : 888 - 897
  • [10] CONTRIBUTION OF THE TATA MOTIF TO TAT-MEDIATED TRANSCRIPTIONAL ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS GENE-EXPRESSION
    OLSEN, HS
    ROSEN, CA
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (09) : 5594 - 5597